Loading clinical trials...
Loading clinical trials...
Prospective, observational study to collect and analyze data on patients with advanced hormone dependent prostate cancer treated with Firmagon® according to routine medical practice in Argentina
Age
18 - 100 years
Sex
MALE
Healthy Volunteers
No
Hospital de Trauma y Emergencia Dr Federico Abete
Ingeniero Pablo Nogués, Buenos Aires, Argentina
Start Date
March 1, 2013
Primary Completion Date
September 3, 2018
Completion Date
September 3, 2018
Last Updated
October 23, 2018
90
ACTUAL participants
Firmagon® (degarelix)
DRUG
Lead Sponsor
Ferring Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions